Internal link ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO April 23, 2018 at 11:00 AM UTC
Internal link ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology April 10, 2018 at 11:00 AM UTC
Internal link ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update Februar 28, 2018 at 12:00 PM UTC
Internal link ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer Februar 27, 2018 at 12:00 PM UTC
Internal link Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A Februar 12, 2018 at 12:00 PM UTC
Internal link ProQR to Present at Upcoming Scientific Meeting and Investor Conference Februar 06, 2018 at 12:00 PM UTC
Internal link ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology Januar 08, 2018 at 12:00 PM UTC